Critics Question World Health Organization's Stance on E-cigarettes

Regulations by 2FIRSTS.ai
Apr.10.2024
Critics Question World Health Organization's Stance on E-cigarettes
World Health Organization's statement on e-cigarette-induced seizures sparks controversy on social media, prompting fact-checking and debate.

According to a report by the Daily Mail, the World Health Organization recently made a statement on the social platform "X", claiming that e-cigarettes can cause seizures within a few hours, which has sparked criticism from various parties. The global health organization's statement on "X" was fact-checked by internet users, and the social platform later released a community statement.

 

Critics Question World Health Organization's Stance on E-cigarettes
Translate to English: WHO post | Image source: X

 

The announcement stated: "The basis of this post is research that has not been peer-reviewed and the evidence is uncertain. The basis of this statement is approximately 120 uncertain events that have occurred since 2019."

 

Dr. Charles Gardner, a developmental neurobiologist in Brooklyn, tweeted, "Please provide peer-reviewed evidence to support the claim that e-cigarettes 'typically' trigger seizures within 24 hours. If you cannot do this, please delete your tweet. Note: I have reviewed the literature and have not found any studies showing that e-cigarettes increase the risk of seizures.

 

In addition, some users have referred to the World Health Organization as clowns and liars, claiming that they are spreading propaganda. Steve Rolles, senior policy analyst at the Transform Drug Policy Foundation, also said, "I am convinced this is nonsense. Why is the World Health Organization's stance on e-cigarettes so peculiarly out of line?"

 

Critics Question World Health Organization's Stance on E-cigarettes
Supplementary statement of the WHO post | Image source: X

 

In a community announcement on "X," a link to an editorial on e-cigarettes and epilepsy was included. The editorial, published in the Journal of Adolescent Health, discusses a 2019 study analyzing 122 cases of seizure and other neurological symptoms in individuals who reported using e-cigarettes in the past 24 hours. Due to its potential to trigger seizures, researchers suggest that participants may be at risk for nicotine-induced epilepsy and symptoms.

 

However, the editorial pointed out that the details of the study "raise questions about causality, which must be considered when assessing the actual health risks of nicotine e-cigarettes for adolescents." It also noted, "A major question is why inhaling nicotine from e-cigarettes can trigger seizures, while inhaling nicotine from traditional tobacco does not.

 

The authors point out that a person would need to inhale a large dose of nicotine to trigger a seizure, but e-cigarette devices contain much lower levels of nicotine compared to traditional cigarettes. Additionally, the toxic effects of high doses of nicotine are expected to appear within minutes of inhalation and dissipate within a few hours. The authors state, "Seizures do not seem likely to occur if there are no other systemic toxic effects present.

 

In the United States, the use of e-cigarettes has reached record levels, with over 17 million adults and 2 million children addicted to these devices. An editorial pointed out a flaw in a 2019 study, stating that the analysis of reported seizures was based on self-reporting and not always clear. Descriptions varied, with some individuals reporting severe seizures while others detailed tremors or seizure-like activity. In most cases, these events were not evaluated by medical professionals. The editorial's author noted that nicotine could potentially cause anxiety attacks and unconscious muscle contractions, leading some individuals to misinterpret these symptoms as seizures, even though they are not.

 

Despite traditional cigarette smoking rates decreasing each year, the number of people using e-cigarettes is continuously increasing, especially among middle and high school students. An analysis from the Centers for Disease Control and Prevention (CDC) in 2023 found that 2.1 million children, or nearly 8% of the student population, are using these devices, with 47% of children who have tried e-cigarettes still currently using them.

 

E-cigarettes typically come in attractive flavors such as cotton candy and caramel custard, and their packaging designs appeal to younger users. Data shows that approximately 90% of young people report having used products with fruit or candy flavors.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
PMI Global R&D Chief Meets Chinese Tobacco Regulator as China Advances Heated Cigarette Standards
PMI Global R&D Chief Meets Chinese Tobacco Regulator as China Advances Heated Cigarette Standards
Philip Morris International’s global R&D chief Michele Cattoni met Liu Sanjiang, deputy director of China’s State Tobacco Monopoly Administration, in Beijing on Aug. 27. The meeting comes as China advances mandatory standards for heated cigarettes and nicotine pouches, laying groundwork for their domestic introduction. Cattoni has held senior roles in PMI’s heated tobacco development, while China’s draft standard covers multiple heating architectures, including systems similar in principle to PMI’s IQOS ILUMA technology.
Aug.27
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s Victoria Steps Up Illegal Tobacco Enforcement With Store Closures and Penalties of Up to A$2.5 Million
Australia’s state of Victoria has activated new powers allowing Tobacco Licensing Victoria and police to shut premises suspected of selling, supplying or possessing illicit tobacco for up to 90 days. Longer closures can be ordered by a magistrates’ court. Businesses subject to closure orders must generally cease all trading and will be placed on a public list. Breaching a closure order can carry penalties of up to A$2.5 million and 20 years in prison.
Sep.10
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18